Maricann to sell soft-gel CBD drug in Germany

A patented 25-mg CBD drug developed by Ontario-based Maricann goes on sale in Germany next week.

Maricann CEO Ben Ward said the development “symbolizes a significant move to strengthen our global leadership position.”

The company says its patented system of drug delivery provides a “precise and consistent solid dosage.”

Mr. Ward said the new formulation is first of many that uses the company’s multi-patented VESIsorb(R) delivery system, designed “to ensure optimum absorption and bioavailability.”

The company claims that close to 200 million consumers in six continents have safely and effectively used a natural product formulated with VESIsorb(R) since 2007.

Jesse Lopez, CEO and founder of SourceOne Global Partners says that: ”Maricann has all of the critical elements to champion the VESIsorb(R) drug delivery system in the emerging global cannabis industry.”

“With a focus on innovation and clinical research, they also have the financial strength to build awareness and educate consumers on these superior product applications.”

Founded in 2013, Maricann is a producer and distributor of cannabis for medical purposes. Based in  Ontario and Munich, Germany, it has production facilities in Langton, Ontario where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada.

The Company also has production operations in Dresden, Saxony, Germany and Regensdorf, Switzerland.

Copyright Notice ©CannabisFindings.com. 2018. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to CannabisFindings.com with appropriate and specific direction to the original content.

One thought on “Maricann to sell soft-gel CBD drug in Germany

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s